Literature DB >> 2427659

Anti-glycolipid antibodies and their immune complexes in multiple sclerosis.

N Kasai, A R Pachner, R K Yu.   

Abstract

Antibody titers against myelin constituents in sera and CSF of patients with multiple sclerosis (MS) were examined by a solid-phase radioimmunoassay. Anti-GM4 and anti-galactocerebroside antibody titers were significantly elevated in the CSF of MS patients, but not anti-GM1 and anti-myelin basic protein antibodies. In sera of MS patients, the titers of antibodies against these myelin constituents were not elevated. Total IgG level was also significantly elevated in the CSF, but not in the sera of MS patients. Immune complexes from the CSF of MS patients were dissociated by acid-ultrafiltration and assayed for antibodies to GM4, GM1, and galactocerebroside. Anti-GM4 and antigalactocerebroside antibody titers were significantly enhanced after acid dissociation and ultrafiltration. These data suggest that antibodies of the IgG class against GM4 and galactocerebroside are present in CSF of MS patients, and a significant number of them exist as immune complexes with their corresponding glycolipid antigens.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2427659     DOI: 10.1016/0022-510x(86)90048-1

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  12 in total

1.  A role for complement in phagocytosis of myelin.

Authors:  B A DeJong; M E Smith
Journal:  Neurochem Res       Date:  1997-04       Impact factor: 3.996

Review 2.  Sphingolipids in multiple sclerosis.

Authors:  Arundhati Jana; Kalipada Pahan
Journal:  Neuromolecular Med       Date:  2010-07-07       Impact factor: 3.843

3.  Anti-galactocerebroside antibodies in human cerebrospinal fluids determined by enzyme-linked immunosorbent assay (ELISA).

Authors:  T Ichioka; K Uobe; M Stoskopf; Y Kishimoto; G Tennekoon; W W Tourtellotte
Journal:  Neurochem Res       Date:  1988-03       Impact factor: 3.996

4.  Autoantibodies against Forssman glycolipids in Graves' disease and Hashimoto's thyroiditis.

Authors:  T Ariga; T Yoshida; T Mimori; R K Yu
Journal:  Clin Exp Immunol       Date:  1991-12       Impact factor: 4.330

Review 5.  Lipids and lipid-reactive antibodies as biomarkers for multiple sclerosis.

Authors:  Francisco J Quintana; Ada Yeste; Howard L Weiner; Ruxandra Covacu
Journal:  J Neuroimmunol       Date:  2012-05-12       Impact factor: 3.478

Review 6.  Autoimmune T-cell reactivity to myelin proteolipids and glycolipids in multiple sclerosis.

Authors:  Judith M Greer
Journal:  Mult Scler Int       Date:  2013-11-07

Review 7.  The Cerebrospinal Fluid in Multiple Sclerosis.

Authors:  Florian Deisenhammer; Henrik Zetterberg; Brit Fitzner; Uwe K Zettl
Journal:  Front Immunol       Date:  2019-04-12       Impact factor: 7.561

8.  Anti-Chol-1 antigen, GQ1bα, antibodies are associated with Alzheimer's disease.

Authors:  Toshio Ariga; Masaru Kubota; Makoto Nakane; Kenji Oguro; Robert K Yu; Susumu Ando
Journal:  PLoS One       Date:  2013-05-23       Impact factor: 3.240

9.  Quantified CSF antibody reactivity against myelin in multiple sclerosis.

Authors:  Xingwen Sun; Mostafa Bakhti; Dirk Fitzner; Mareike Schnaars; Niels Kruse; Ünal Coskun; Christiane Kremser; Klaus Willecke; Ludwig Kappos; Jens Kuhle; Mikael Simons
Journal:  Ann Clin Transl Neurol       Date:  2015-11-09       Impact factor: 4.511

10.  Serum antibodies to phosphatidylcholine in MS.

Authors:  Maria Cruz Sádaba; Veit Rothhammer; Úrsula Muñoz; Cristina Sebal; Esther Escudero; Pia Kivisäkk; Maria Isabel Garcia Sanchez; Guillermo Izquierdo; Stephen L Hauser; Sergio E Baranzini; Jorge R Oksenberg; Roberto Álvarez-Lafuente; Rohit Bakshi; Howard L Weiner; Francisco J Quintana
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2020-06-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.